For research use only. Not for human consumption. Affiliate links may earn commissions. Not medical advice.
Back to Catalog
Retatrutide
144h half-life
MW: 4731.33
≥98–99.4%
Retatrutide is an experimental triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, designed for significant fat loss, metabolic improvement, and body recomposition in obesity research.
Compare suppliers below for purity, pricing, and availability from vetted research vendors.
Common Research Uses
Fat loss
appetite suppression
glycemic control
obesity research
energy expenditure increase
Compare Suppliers
No variants or suppliers have been added yet.
COA / Third-Party Testing
Vetted suppliers provide third-party Certificates of Analysis (COAs). Always verify COAs independently on the supplier's website before purchasing.
Why Compare Here?
We aggregate vetted research suppliers for transparency. Always verify COAs independently.
Affiliate Disclosure: Links on this page may be affiliate links. We may earn a commission at no extra cost to you.